Our Cardiac biomarker reader NanoBot, currently under development, is a point-of-care in-vitro diagnostic testing system that measures the cardiac biomarker b-type natriuretic peptides (BNP) in blood quantitatively to aid the diagnosis of heart failure. Our system utilizes nanomaterial-based sensor technology that can measure BNP concentration rapidly and accurately with one drop of blood.
The system operates like a blood glucose meter, where patient simply prick his/her finger using a lancet and fill the NanoBot test strip with finger-prick blood. Within a short time, the level of BNP will be displayed on the reader screen.
Our system is designed to deliver fast and accurate results at point-of-care such as clinics and patient home. For home use, the test results will be transferred to patient’s smartphone, which will then be uploaded to cloud server that can be access by doctors.